Drug LitigationUncategorizedHow Much Do We Know About Celexa?

November 9, 2011

Not enough. Celexa, a widely prescribed antidepressant known as a selective serotonin reuptake inhibitor (SSRI), threatens the health of developing babies when consumed by pregnant women. How serious are the risks? According to one recent study, children in the womb experienced a six-fold increase in the probability of developing persistent pulmonary hypertension (PPHN) when their mother’s an SSRI drug like Celexa after the 20th week of pregnancy.

 

Some medical experts worry that the threats imposed by Celexa aren’t just what the medical community already knows about this dangerous drug, but what its still learning. How will Celexa-exposed children develop during later childhood? How will non-physical characteristics, such as emotional wellbeing, be impacted by prenatal Celexa exposure? As important as these questions are, the disconcerting reality is that we don’t know the answer—even as some doctors still prescribe SSRIs to pregnant patients.

 

Nachawati Law Group attorneys fight for victims of Celexa injuries. We know how this dangerous drug impacts consumers like you—and we’re ready to defend your legal rights and advance your valid financial claims. You and your family don’t have to suffer in silence. Find out how we’re helping SSRI victims by contact us today. For a free consultation, call us at 1.866.545.8364 or email [email protected]

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy